Analysen von Richard Vosser
| 06.08.19 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 05.08.19 | Bayer Neutral | JP Morgan Chase & Co. | |
| 05.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 31.07.19 | Bayer Neutral | JP Morgan Chase & Co. | |
| 30.07.19 | Bayer Neutral | JP Morgan Chase & Co. | |
| 30.07.19 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 29.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 29.07.19 | Novartis Underweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 24.07.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 19.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 19.07.19 | Bayer Neutral | JP Morgan Chase & Co. | |
| 18.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 16.07.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 16.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 15.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 15.07.19 | Bayer Neutral | JP Morgan Chase & Co. | |
| 08.07.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.07.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 03.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 01.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 28.06.19 | Roche overweight | JP Morgan Chase & Co. | |
| 12.06.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.06.19 | Roche overweight | JP Morgan Chase & Co. | |
| 04.06.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 04.06.19 | Merck Neutral | JP Morgan Chase & Co. | |
| 03.06.19 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 03.06.19 | Roche overweight | JP Morgan Chase & Co. | |
| 03.06.19 | Bayer Neutral | JP Morgan Chase & Co. | |
| 29.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 29.05.19 | Roche overweight | JP Morgan Chase & Co. | |
| 29.05.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 24.05.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 16.05.19 | Roche overweight | JP Morgan Chase & Co. | |
| 14.05.19 | Merck Neutral | JP Morgan Chase & Co. | |
| 14.05.19 | Bayer Neutral | JP Morgan Chase & Co. | |
| 13.05.19 | Merck Neutral | JP Morgan Chase & Co. | |
| 09.05.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 08.05.19 | Roche overweight | JP Morgan Chase & Co. | |
| 07.05.19 | Merck Neutral | JP Morgan Chase & Co. | |
| 06.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.05.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 03.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 29.04.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 29.04.19 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 26.04.19 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 25.04.19 | Bayer Neutral | JP Morgan Chase & Co. | |
| 25.04.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 24.04.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 23.04.19 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 17.04.19 | Novartis Underweight | JP Morgan Chase & Co. | |